SEK 0.56
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Founded in Södertälje, Sweden, in 2004, Nanologica AB (publ) is a nanotechnology company dedicated to creating nanoporous silica. This specialized material finds critical applications within the life science industry, particularly in drug development and chromatography separation. The firm's comprehensive product line features the NLAB Silica platform for advanced drug delivery, the NLAB Spiro inhalation platform targeting pulmonary administration, SVEA (U)HPLC analytical columns, and systems for preparative chromatography.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E.
Data is available to registered users only